Obesity
Donald Trump
Open Ai
Civic Engagement
State Flags
Kilmar Abrego Garcia
Jordon Hudson
Mississippi
Minnesota
Economic Policy
Political Polarization
Obesity
CNN - Apr 29th, 2025
What are your questions about Trump’s impact on children’s health?
Trump's second term reshapes child health amid measles crisis
New York Post - Mar 29th, 2025
Bizarre NYC pizza ad that name-drops Wegovy is is sparking outrage: ‘This is crazy’
NYC pizza-bagel shop's weight-loss drug ad sparks outrage and debate.
Pr Newswire - Dec 18th, 2024
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model
In a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg, subcutaneous (SQ), once every four weeks plus semaglutide, 30 nmol/kg, SQ, once daily), demonstrated superior weight loss compared to semaglutide monotherapy (30 nmol/kg, SQ, once daily),...
Previous
Next
Showing 1 to 3 of 3 results